← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED
IMPHARMA2026 — 2026 — Not specified, Copenhagen, Denmark
Global Medical Health & Pharmaceutical Industry Conference 2026 brings together doctors, scientists, pharma experts, and healthcare leaders to explore medical innovations, drug development, biotechnology, and clinical research. Join us in 2026 for expert sessions, networking, and
1,000+ Attendees
4 Presentations
4 Companies
2 Drugs
Presentation data updated Jun 5, 2026, 11:24 AM UTC
Nova Event Impact Score
55 /100
- Media coverage 14/20
- Speaker quality 16/20
- Pipeline relevance 1/20
- Historical influence 16/20
- Company participation 8/20
Key Takeaways
Key Themes
generalInSciTech SummitsPipeline announcementsPartnership deals
Key Companies
NovartisTeva Pharmaceutical Industries Ltd.Undisclosed biopharma companyInnate Pharma
Key Drugs
pelacarsenfremanezumab
Key Markets
Europe
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Investors & analysts
Full Schedule
LATE BREAKER
LATE-BREAKER Jun 16
Phase III Lp(a)HORIZON Study of Pelacarsen: Readout Results
PLENARY
PLENARY Jun 15
Phase III Data: Biopharma Company Study Met Dual Primary Endpoints with 71% Reduction in Risk
ORAL
ORAL Jun 15
MATISSE Phase 2 Interim Analysis: Dual Inhibition of CD39 and PD-L1 Pathways with Chemotherapy in Anti-Tumor Activity
POSTER
POSTER Jun 17
Phase III Data: Teva's Ajovy (fremanezumab) in Migraine Prevention